Acquiring Company
Anagenics
Acquired Company
Bio-First
AustraliaAustraliaBiotechnologyHealth CareHealth CareE CommerceBeautyCosmeticsDescription
Anagenics has entered a binding agreement to acquire Australian skin-health brand Bio-First from Bio deNovo Group for $50,000. The all-scrip deal is payable in 8,333,333 shares at $0.006 each. The transaction is scheduled to complete upon share issuance during November, and Anagenics plans to relaunch core products while conducting a wider portfolio review.
Quick answer
Anagenics is acquiring Bio-First for $0.1 million, announced November 11, 2026. Anagenics is based in Australia.
- How much did Anagenics pay for Bio-First?
- The reported deal value is $0.1 million.
- What does Anagenics do?
- Anagenics is an Australian-listed company (ASX:AN1) that entered into a binding agreement to acquire the skin-health brand Bio-First.
- Where are Anagenics and Bio-First based?
- Anagenics is based in Australia. Bio-First is based in Australia.
Source: Fundz verified event record.
Other recent acquisitions in E Commerce and Beauty
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Galderma to acquire ZO Skin Health for skincare boost (October 14, 2026)
- L'Oreal acquires Dr.G for U.S. market expansion (October 5, 2026)
- Clicks acquires controlling stake in ARC retailer (September 28, 2026)
- The Center Brands acquires Boscia from FANCL (October 26, 2026)
- Tresalis acquires Vyrao for wellness brand growth (September 30, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
Who to call at Anagenics, and when
When Anagenics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Anagenics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anagenics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anagenics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anagenics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Bio-First?
Bio-First was acquired by Anagenics, based in Australia. The deal was reported on November 11, 2026. Anagenics is an Australian-listed company (ASX:AN1) that entered into a binding agreement to acquire the skin-health brand Bio-First. Anagenics is privately held and operates in Biotechnology.
When did Anagenics acquire Bio-First?
Anagenics's acquisition of Bio-First was reported on November 11, 2026. Anagenics has entered a binding agreement to acquire Australian skin-health brand Bio-First from Bio deNovo Group for $50,000. The all-scrip deal is payable in 8,333,333 shares at $0.006 each. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bio-First do?
Bio-First is an Australian natural skin-health brand. The purchase includes its brand assets, customer records, and more than 10 product concepts. It is privately held, operating in Health Care, and is based in Australia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.